Glucose Health, Inc. (GLUC) intrinsic value & 10-year financials
Glucose Health, Inc. (GLUC) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 8 fiscal years revenue grew 125.1% a year to $313.2K, with an average return on invested capital of 546.9%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $0.36
- Revenue (FY2016)
- $313.2K
- Revenue growth (8-yr CAGR)
- 125.1%
- ROIC (10-yr avg)
- 546.9%
- Free cash flow (FY2016)
- —
GLUC 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2016 | $313.2K | -$410.4K | — | — | -27.7% | 92.9% |
| FY2015 | $4.3K | -$266.1K | — | — | -3655.7% | 79.6% |
| FY2014 | $2.7K | -$669.4K | — | — | -19905.7% | 279.9% |
| FY2013 | -$224 | -$2.0M | — | — | 804358.5% | 2310.1% |
| FY2012 | — | -$568.6K | — | — | — | 694.2% |
| FY2011 | — | -$899.2K | — | — | — | 230.4% |
| FY2010 | $2.4K | -$632.7K | — | — | -25554.8% | 141.3% |
| FY2009 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Glucose Health, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Glucose Health, Inc. has earned high returns on invested capital, averaging 49.9% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
Glucose Health, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Glucose Health, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment.